ALLMedicine™ Acidosis Center
Research & Reviews 5,279 results
https://doi.org/10.1016/j.jstrokecerebrovasdis.2023.107080
Journal of Stroke and Cerebrovascular Diseases : the Offi... Murakami K, Sakamoto K et. al.
Mar 19th, 2023 - A 40-year-old man with sensorineural hearing loss and diabetes mellitus was hospitalized with acute-onset impaired consciousness and clumsiness in his left hand. He had been taking metformin for 4 months. A neurological examination revealed confus...
https://doi.org/10.1055/a-2057-7385
American Journal of Perinatology; Razek Midan DA, Eigendy FM et. al.
Mar 19th, 2023 - The aim of this study was to assess the Neonatal Resuscitation and Adaptation Score (NRAS) value compared to the conventional and combined Apgar scores in predicting neonatal morbidity and mortality. A prospective cohort study was conducted on 289...
https://doi.org/10.1080/02770903.2023.2191715
The Journal of Asthma : Official Journal of the Associati... Kolli S, Opolka C et. al.
Mar 18th, 2023 - Severe, refractory asthma is a life-threatening emergency that may be treated with isoflurane and extracorporeal life support. The objective of this study was to describe the clinical response to isoflurane and outcomes after discharge of children...
https://doi.org/10.1007/s00262-023-03376-9
Cancer Immunology, Immunotherapy : CII; Semeniuk-Wojtaś A, Poddębniak-Strama K et. al.
Mar 18th, 2023 - Bladder cancer (BC) can be divided into two subgroups depending on invasion of the muscular layer: non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). Its aggressiveness is associated, inter alia, with genetic abe...
https://doi.org/10.1016/j.ajem.2023.02.038
The American Journal of Emergency Medicine; Lewis B, Brooks D et. al.
Mar 18th, 2023 - A 53-year-old man died following a reported ingestion of 80 g of his metformin tablets resulting in severe, refractory shock and metformin-associated lactic acidosis. His peak serum metformin concentration was 53 μg/mL (therapeutic range 1-2 μg/mL...
Guidelines 2 results
https://doi.org/10.1097/CCM.0000000000002027
Critical Care Medicine; Murray MJ, DeBlock H et. al.
Oct 19th, 2016 - To update the 2002 version of "Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient." A Task Force comprising 17 members of the Society of Critical Medicine with particular expertise in the use of n...
https://doi.org/10.1097/TA.0b013e31827019de
The Journal of Trauma and Acute Care Surgery; Maung AA, Johnson DC et. al.
Dec 27th, 2012 - Small-bowel obstruction (SBO) represents as many as 16% of surgical admissions and more than 300,000 operations annually in the United States. The optimal strategies for the diagnosis and management of SBO continue to evolve secondary to advances ...
Drugs 230 results see all →
Clinicaltrials.gov 498 results
https://clinicaltrials.gov/ct2/show/NCT04926740
Mar 8th, 2023 - BACKGROUND AND SIGNIFICANCE Diabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes which requires treatment with intravenous (IV) fluid and insulin to correct hyperglycemia and reverse acidosis. Current DKA management g...
https://clinicaltrials.gov/ct2/show/NCT00027274
Mar 7th, 2023 - Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic ca...
https://clinicaltrials.gov/ct2/show/NCT04620629
Mar 6th, 2023 - Lactic acid exists as two optical isomers, L-lactic acid and D-lactic acid. These isomers are metabolized to or synthesized from pyruvate by the action of isomer-specific enzymes (L-lactate dehydrogenase and D-lactate dehydrogenase). Mammals, incl...
https://clinicaltrials.gov/ct2/show/NCT04934163
Mar 6th, 2023 - This is a single-center, open-label, randomized controlled trial to evaluate the effect of high-flow nasal cannula with a flow rate of 60 L/min versus 40 L/min after planned extubationon on a composite outcome of reintubation and use of NIV in pat...
https://clinicaltrials.gov/ct2/show/NCT05752279
Mar 2nd, 2023 - DKA is a life-threatening complication of diabetes mellitus, described in patients with both type-1 diabetes, and type-2 diabetes(1). Data from the Australian Institute of Health and Welfare suggest that between 2009-10 to 2014-15, there has been ...
News 372 results
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/372428
Diabetes is a common chronic condition and as of 2015, approximately 30 million persons in the United States had diabetes (23 million with diagnosed and 7 million with undiagnosed) (1). Diabetic ketoacidosis (DKA) is a life-threatening but prevent...
https://www.medpagetoday.com/endocrinology/diabetes/102754
Jan 23rd, 2023 - The first oral SGLT2 inhibitor approved by the FDA for treating diabetes in cats is now approved for humans with the disease, drugmaker TheracosBio announced. As an adjunct to diet and exercise, the oral treatment is indicated for adults with type...
https://www.medpagetoday.com/endocrinology/diabetes/102293
Dec 19th, 2022 - Among people with type 2 diabetes, use of metformin might help to stave off total joint replacement, a population-based cohort study showed. Among over 40,000 patients, daily metformin was associated with a 30% lower risk for total knee and hip re...
https://www.mdedge.com/familymedicine/article/259645/endocrinology
MDedge Family Medicine; Christopher W. Ferguson, DO, Brodrick E. Hirai, MD et. al.
Nov 21st, 2022 - THE CASE A 26-year-old woman presented to the emergency department (ED) with a history of nausea and vomiting for more than 24 hours. The vomiting began when she awoke to breastfeed her 3-month-old infant.
https://www.onclive.com/view/nivolumab-ipilimumab-plus-cbm588-generates-superior-efficacy-in-metastatic-rcc
Nov 7th, 2022 - The addition of CBM588, a live probiotic comprised primarily of Clostridium butyricum, to the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) produced superior response rates and a progression-free survival (PFS) benefit vs nivolumab plu...